BDBM79450 (4-cyclohexyl-1-piperazinyl)-[3-[(3-hydroxy-1-piperidinyl)methyl]-2-imidazo[1,2-a]pyridinyl]methanone::(4-cyclohexylpiperazin-1-yl)-[3-[(3-hydroxypiperidin-1-yl)methyl]imidazo[1,2-a]pyridin-2-yl]methanone::(4-cyclohexylpiperazin-1-yl)-[3-[(3-oxidanylpiperidin-1-yl)methyl]imidazo[1,2-a]pyridin-2-yl]methanone::(4-cyclohexylpiperazino)-[3-[(3-hydroxypiperidino)methyl]imidazo[1,2-a]pyridin-2-yl]methanone::SR-01000180668::SR-01000180668-2::cid_24818987

SMILES N[C@H]1CC[C@@H](N2CCC3CC2c2cc(-c4cccc(C(F)(F)F)c4)ccc23)CC1

InChI Key InChIKey=NSNYNXHVYHCKFB-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 79450   

TargetSigma intracellular receptor 2(Human)
University of Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 79450BDBM79450(US20250387403, Example Table1.28)
Affinity DataKi:  7.90nMAssay Description:Keywords: apoptosis, BH3 domain, Bcl2-A1, BIM, caspase, cancer Primary Collaborator: Todd Golub, Broad Institute, golub@broadinstitute.org Assay Over...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/6/2026
Entry Details
US Patent